Argent BioPharma Ltd.

A clinical-stage biopharmaceutical company focused on developing and marketing innovative drugs using nanotechnology and a multidisciplinary approach.

Biotechnology
public
Subiaco, Australia Founded 2015
Website ↗
Last updated 2026-08-22
Total raised
—
Stage
—
Founded
2015
Headcount
—
HQ
Subiaco, Australia
Sector
Biotechnology

About

Argent BioPharma Ltd. is a clinical-stage biopharmaceutical company that develops nano-engineered therapeutics to reset the balance between the nervous and immune systems. The company focuses on addressing unmet medical needs, particularly in the central nervous system (CNS) and autoimmune system, through its in-house R&D platform. Its product candidates include CannEpil for refractory epilepsy, CimetrA for acute lung injury and ARDS, and CogniCann for dementia and Alzheimer's patients. The company rebranded from MGC Pharmaceuticals in March 2026.

Team · 13

Roby Reuven Zomer
Founder · Director, Chief Executive Officer and Managing Director
Andrew Chapman
Executive Director
Daniel Robinson
Non-Executive Independent Director
Gary Hermon
Non-Executive Director
Rowan Harland
Company Secretary
Ross Grant Thomas Walker
Chairman of Strategic Advisory Board
Uri Kramer
Member of Strategic Advisory Board
Wendyl D'Souza
Member of Medical Advisory Board
Shlomo Sadoun
Member of Advisory Board
Amir Polak
executives
Yair Tal
executives
Dr. Jonathan Grunfeld
executives
Ana Arhar Oblak
executives

Sectors & technology

Primary sector
Biotechnology
Technologies
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)